Fragile X Syndrome: Inheritance, Symptoms, Treatment, and Pregnancy Implications
Fragile X syndrome is the most common inherited cause of intellectual disability, resulting from a mutation in the FMR1 gene on the X chromosome that leads to absence of the fragile X mental retardation protein (FMRP), causing characteristic cognitive, behavioral, and physical features.
Genetics and Inheritance Pattern
Fragile X syndrome follows an X-linked inheritance pattern with unique characteristics:
- Located on chromosome Xq27.3 in the FMR1 gene 1
- Caused by expansion of CGG repeats in the 5' untranslated region of the FMR1 gene 1
- Classification based on repeat size:
The inheritance pattern has distinctive features:
- Full mutations are penetrant in all males and many females 1
- Expansion from premutation to full mutation almost exclusively occurs during maternal transmission 1
- The mutation is a multistep expansion occurring over generations 1
- Males with full mutations are typically more severely affected than females due to X-inactivation in females 2
Clinical Features and Symptoms
Cognitive and Behavioral Features
- Intellectual disability (variable severity, more severe in males) 1, 2
- Speech and language delays 3
- Learning difficulties 1, 3
- Attention deficits and hyperactivity 3, 4
- Anxiety 3, 4
- Impulsivity 4
- Autism spectrum features (poor eye contact, hand flapping, hand biting) 4
- Sleep problems 3
Physical Features
- Long face with prominent ears
- Macro-orchidism (enlarged testicles) in post-pubertal males
- Joint hypermobility
- Mitral valve prolapse
- High-arched palate 4
Premutation-Associated Conditions
Individuals with premutations (55-200 CGG repeats) may develop:
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) 1, 2:
- Late-onset progressive neurological disorder
- Intention tremor and ataxia
- Progressive cognitive decline
- Memory loss, anxiety, executive function deficits
- Higher risk in males than females
- Penetrance increases with age and premutation repeat length 1
Fragile X-associated Primary Ovarian Insufficiency (FXPOI) 1, 2:
- Affects approximately 20% of female premutation carriers
- Usually occurs with >80 CGG repeats
- Leads to premature menopause and fertility issues 1
Diagnosis
Molecular genetic testing is the gold standard for diagnosis:
- DNA-based testing to determine CGG repeat number in FMR1 gene
- Southern blot analysis and PCR techniques are commonly used 1
- Testing is indicated for:
- Individuals with intellectual disability, developmental delay, or autism
- Family members of known carriers
- Women with premature ovarian insufficiency
- Older adults with progressive tremor/ataxia 1
Treatment Approaches
There is no cure for fragile X syndrome, but management focuses on symptom control:
Non-pharmacological interventions:
- Speech and language therapy
- Occupational therapy
- Special education services
- Behavioral therapy 3
Pharmacological treatments:
- No FDA-approved medications specifically for fragile X syndrome
- Symptom-based medication management:
- Stimulants for ADHD symptoms
- SSRIs for anxiety
- Antipsychotics for aggression or severe behavioral issues
- Targeted treatments showing promise:
- Metformin
- Sertraline
- Cannabidiol 3
Emerging therapies:
- Gene therapy approaches are in development and show potential for future treatment 3
Pregnancy and Genetic Counseling Implications
For women with fragile X premutations or full mutations:
Reproductive considerations:
Transmission risks:
- Female premutation carriers have risk of expansion to full mutation when transmitted to offspring
- Males with premutation typically pass the premutation (not full mutation) to all daughters
- Males with full mutation do not typically transmit the full mutation as sperm usually carry premutations
Prenatal testing options:
- Amniocentesis or chorionic villus sampling with FMR1 testing
- Preimplantation genetic diagnosis for at-risk couples
Family screening:
- Cascade testing of family members is recommended when a diagnosis is made
- Allows identification of premutation carriers who may be at risk for FXTAS or FXPOI 1
Clinical Pearls and Pitfalls
- Fragile X syndrome must be considered in the differential diagnosis of any child with developmental delay, intellectual disability, or autism spectrum disorder 5
- Premutation carriers may appear unaffected in early life but develop FXTAS or FXPOI later in life 1, 2
- The severity of symptoms in females with full mutations is highly variable due to X-inactivation patterns
- Genetic counseling is complex due to the risk of expansion from premutation to full mutation during maternal transmission
- Limited awareness and poor access to genetic services remain significant challenges, particularly in resource-limited settings 6